Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 earnings call transcript

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.

How CRISPR Works: Unpacking the Science of Cas9 and Gene Modification

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
James Halliday Australian Wine Companion

Going door to door: Max Veenhuyzen on Margaret River's cellar doors

Free-spirited, feelgood and, crucially, fun: a new crop of Margaret River cellar doors is changing the way people drink and think about wine. Max Veenhuyzen checks in with local vignerons doing ...
The Cool Hour

Eckhaus Latta Fall 2026 Highlights Striped Knits, Cutout Denim, and Textured Black Layers

Eckhaus Latta Fall 2026 at New York Fashion Week featured striped knits, cutout denim, high waisted leather skirts, and ...